Dean Calhoun is an American Board of Industrial Hygiene Certified Industrial Hygienist (CIH). He has been an environmental health and safety professional for over 33 years.

Prior to starting Affygility Solutions, Dean was the Associate Director of Environmental Health and Safety for Gilead Sciences, Inc., a biopharmaceutical company focused on developing pharmaceuticals for infectious, viral, and oncology applications. His experiences including development and implementation of global EHS guidelines, implementation and coordination of an executive management EHS Steering Committee, establishment of occupational exposure limits for pharmaceutical active ingredients, industrial hygiene program management, and EH&S auditing of research, manufacturing and contract manufacturing facilities.

Dean is an international speaker on the topic of potent compound safety and has presented at conferences throughout the United States, Europe, and Asia.

Dean graduated with a B.Sc. degree in Engineering from the University of Wyoming and has dual master degrees in Environmental Policy and Management, and Technology Management from the University of Denver. He is a member of AIHA, ISPE, and NAEM.

William A. Hawkins BSc (Hons), MSc, CBiol, MSOB, ERT is a Managing Toxicologist for SafeBridge Regulatory and Life Sciences Group. He has spent over 21-years working in toxicology, with experience in REACH, GHS and SDSs, as a study director and a consumer safety toxicologist.  He has practiced as an Occupational Toxicologist within the pharmaceutical industry for the last 11-years.  Professional recognition of current practice in toxicology is recognized by the award of UK Chartered Biologist and European Registered Toxicologist.

Justin Mason-Home is founder and Director of HPAPI Project Services Limited. He is an organic chemist and a Fellow of the Royal Society of Chemistry, with global, senior level, strategic, potent drug safety experience.

In the last 23 years of his career, he has dealt with some of the most serious and sensitive highly potent, toxic and dangerous pharmaceutical occupational, health and safety matters in the biopharmaceutical industry. He has presented extensively on the subject and chaired a number of global conferences on highly potent APIs.

For the last 11½ years, Justin was Managing Director for Europe of a well-known potent drug occupational health and safety consulting firm, before leaving, forming his own company and pursuing other business interests.

During his career, Justin has provided professional consulting advice within many hundreds of projects including commercial M&A due diligence work, potent drug manufacturing conceptual and detailed design work, corporate potent drug management systems, exposure incident investigation and defence work, facility health safety and environmental assessments, control and containment equipment selection advice, occupational hygiene and a comprehensive range of related work, including giving direct advice at board level. Previously as a Principal Consultant and as a company Director he has been responsible for managing other professionals and in developing, establishing and maintaining the quality of work delivered to clients.

Martin Kohan has done his BSc/MSc in Biochemistry from La Plata National University, Argentina; MSc in Pharmacology and PhD in Medical Sciences both from the Hebrew University of Jerusalem, Israel. Over 9 years of industry experience in the field of Toxicology conducting and managing over 900 hazard assessments, including calculation of exposure limits and/or determination of exposure control bands of drug substances and of their intermediates for Teva (2010 to 2018) and AstraZeneca (2018 to present). Diplomate of the American Board of Toxicology (DABT), European Registered Toxicologist (ERT), and Member of the UK Register of Toxicologists and of the British Toxicology Society

Mr. Pietro Virgilio has more than 25 years professional experience in the design of pharmaceutical facilities, especially in isolator technology, containment processes, decontamination and sterilization. He has been working for different equipment manufacturers and engineering companies, all in the GMP regulated business.  Pietro’s current position is Process Manager for Biopharma applications at Exyte Italy.